Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review
- PMID: 19945904
- DOI: 10.1016/j.parkreldis.2009.11.004
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review
Abstract
Background: The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease. Knowledge of its worldwide frequency distribution is essential for clinical and molecular research as well as genetic counseling.
Objectives: To conduct a systematic review of the reported frequency of G2019S in different populations and to assess critically the quality of the clinical studies.
Methods: We conducted a systematic review of all published papers on G2019S frequency in homogeneous ethnic groups or sub-groups of patients. Selected papers were analyzed for methodological quality.
Results: 68 studies from 32 countries were included in the analysis. A heterogeneous distribution was observed with high frequencies in North African Arab countries, the Middle East, southern Europe, North American Ashkenazi Jewish populations and in South American countries with known European ethnic influence. Frequencies ranged from the no cases to 35.7% in sporadic and 42% in familial North-African Arab patients. Only one paper from one sub-Saharan country was found. Methodological pitfalls were identified.
Conclusions: Estimated frequencies were found to be variable, which may reflect ethnic differences and methodological discrepancies. We make recommendations on the methods of selection of participants and on the definition of familial Parkinson's disease to improve the quality of frequency studies on LRRK2 mutations.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.Hum Mol Genet. 2010 May 15;19(10):1998-2004. doi: 10.1093/hmg/ddq081. Epub 2010 Mar 2. Hum Mol Genet. 2010. PMID: 20197411
-
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?Neurology. 2007 Oct 16;69(16):1595-602. doi: 10.1212/01.wnl.0000277637.33328.d8. Neurology. 2007. PMID: 17938369
-
LRRK2 G2019S in the North African population: a review.Eur Neurol. 2010;63(6):321-5. doi: 10.1159/000279653. Epub 2010 Apr 23. Eur Neurol. 2010. PMID: 20413974 Review.
-
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.J Neural Transm (Vienna). 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0. J Neural Transm (Vienna). 2009. PMID: 19756366 Review.
-
LRRK2 in Parkinson's disease: genetic and clinical studies from patients.FEBS J. 2009 Nov;276(22):6455-63. doi: 10.1111/j.1742-4658.2009.07344.x. Epub 2009 Oct 5. FEBS J. 2009. PMID: 19804413 Review.
Cited by
-
Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models.ACS Chem Neurosci. 2012 Mar 21;3(3):151-60. doi: 10.1021/cn200117j. Epub 2012 Jan 18. ACS Chem Neurosci. 2012. PMID: 22860184 Free PMC article. Review.
-
Air Pollutants and Risk of Parkinson's Disease among Women in the Sister Study.Environ Health Perspect. 2024 Jan;132(1):17001. doi: 10.1289/EHP13009. Epub 2024 Jan 4. Environ Health Perspect. 2024. PMID: 38175185 Free PMC article.
-
Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's disease.Neurogenetics. 2019 Oct;20(4):215-218. doi: 10.1007/s10048-019-00588-z. Epub 2019 Sep 6. Neurogenetics. 2019. PMID: 31493133
-
Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.PLoS One. 2018 Dec 3;13(12):e0207984. doi: 10.1371/journal.pone.0207984. eCollection 2018. PLoS One. 2018. PMID: 30507963 Free PMC article.
-
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.Neurobiol Dis. 2023 Nov;188:106338. doi: 10.1016/j.nbd.2023.106338. Epub 2023 Oct 29. Neurobiol Dis. 2023. PMID: 38435455 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical